These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 2859589

  • 1. [Current concepts of the pancreatic and extrapancreatic mechanisms of the action of peroral hypoglycemic sulfonylurea preparations].
    Poltorak VV, Gladkikh AI.
    Probl Endokrinol (Mosk); 1985; 31(2):76-85. PubMed ID: 2859589
    [No Abstract] [Full Text] [Related]

  • 2. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
    Beyer J, Haupt E, Cordes U, Kutschera J, Schöffling K.
    Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346
    [No Abstract] [Full Text] [Related]

  • 3. Special pharmacology of the new sulfonylurea glimepiride.
    Geisen K.
    Arzneimittelforschung; 1988 Aug; 38(8):1120-30. PubMed ID: 2904269
    [Abstract] [Full Text] [Related]

  • 4. [Effect of a new sulfonylurea on insulin and glucagon secretion in the isolated perfused pancreas].
    Laube H, Fussgänger RD, Schröder KE, Pfeiffer EF.
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2186. PubMed ID: 4579624
    [No Abstract] [Full Text] [Related]

  • 5. Mechanism of action of sulphonylureas with special reference to the extrapancreatic effect: an overview.
    Beck-Nielsen H, Hother-Nielsen O, Pedersen O.
    Diabet Med; 1988 Oct; 5(7):613-20. PubMed ID: 2975544
    [No Abstract] [Full Text] [Related]

  • 6. Effects of glimepiride and glibenclamide on insulin and glucagon secretion by the perfused rat pancreas.
    Ledercq-Meyer V, Akkan AG, Marchand J, Malaisse WJ.
    Biochem Pharmacol; 1991 Sep 27; 42(8):1634-7. PubMed ID: 1930290
    [Abstract] [Full Text] [Related]

  • 7. Uptake of glibornuride by microdissected pancreatic islets.
    Täljedal IB.
    Horm Res; 1974 Sep 27; 5(4):211-6. PubMed ID: 4210148
    [No Abstract] [Full Text] [Related]

  • 8. Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man.
    Pfeifer MA, Halter JB, Judzewitsch RG, Beard JC, Best JD, Ward WK, Porte D.
    Diabetes Care; 1984 Sep 27; 7 Suppl 1():25-34. PubMed ID: 6376026
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Mode of action of oral hypoglycemic sulfonylureas].
    Paes E.
    Rev Iber Endocrinol; 1972 Sep 27; 19(113):449-59. PubMed ID: 4563178
    [No Abstract] [Full Text] [Related]

  • 14. Pancreatic action of the sulfonylureas.
    Grodsky GM, Epstein GH, Fanska R, Karam JH.
    Fed Proc; 1977 Dec 27; 36(13):2714-9. PubMed ID: 200493
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A, Mariani MM, Ribes G, Alric R.
    Acta Diabetol Lat; 1973 Dec 27; 10(2):261-82. PubMed ID: 4200675
    [No Abstract] [Full Text] [Related]

  • 16. New horizons in our knowledge of diabetes mellitus.
    Levine R.
    J Am Geriatr Soc; 1971 Nov 27; 19(11):897-908. PubMed ID: 4949263
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacodynamic aspects of two sulphonylurea derivatives glipizide and glibenclamide.
    Artini D, Abbiati R, Orsini G, Parenti MA, Bloch K, Daturi S, Mandelli V.
    Diabetologia; 1973 Sep 27; ():311-6. PubMed ID: 4204091
    [No Abstract] [Full Text] [Related]

  • 18. Glucagon secretion from the isolated perfused rat pancreas: influenced by the glucose-, tolbutamide- and pancreozymin-mediated release of pancreatic insulin.
    Fussgänger RD, Goberna R, Laube H, Schröder KE, Straub K, Pfeiffer EF.
    Isr J Med Sci; 1972 Jun 27; 8(6):768-9. PubMed ID: 4559419
    [No Abstract] [Full Text] [Related]

  • 19. [The present status of the question of the mechanism of action of sulfanilamide hypoglycemic preparations and several aspects of their use in the treatment of diabetes mellitus].
    Mordkovskaia NM.
    Probl Endokrinol (Mosk); 1971 Jun 27; 17(5):121-5. PubMed ID: 4337075
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.